Neuroendocrine Carcinoma

general

An aggressive carcinoma composed of malignant cells that exhibit neuroendocrine differentiation. It is classified as small cell or large cell neuroendocrine carcinoma.

50

Centers

19

Active Trials

$1.7B

Cancer Funding

Specific Cancer Types(2)

Top Centers for Neuroendocrine Carcinoma(50)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
89.7
2
NCI Comprehensive
High-Volume Research Center
82.6
3
High-Volume Research Center
71.1
466.2
5
NCI Comprehensive
Active Research Program
66.2
6
NCI Comprehensive
Active Research Program
66.2
7
NCI Comprehensive
Active Research Program
66.2
8
NCI Clinical
Active Research Program
66.2
9
Active Research Program
66.2
10
NCI Comprehensive
Active Research Program
66.2
11
NCI Comprehensive
Active Research Program
62.6
12
NCI Comprehensive
Active Research Program
61.8
1344.7
1444.7
15
NCI Comprehensive
44.7
16
NCI Comprehensive
44.7
17
NCI Comprehensive
44.7
18
NCI Comprehensive
44.7
1944.7
2044.7
2144.7
22
NCI Comprehensive
44.7
23
NCI Comprehensive
44.7
24
NCI Comprehensive
44.7
2544.7
26
NCI Comprehensive
44.7
2744.7
28
Cedars-Sinai CancerLos Angeles, CA
44.7
2944.7
3044.7
31
NCI Comprehensive
44.7
32
NCI Comprehensive
44.7
33
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
44.7
3444.7
3544.7
3644.7
37
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
44.7
3844.7
3944.7
4044.7
4144.7
4244.7
4344.7
4444.7
45
BC CancerVancouver, BC
44.7
4644.7
47
NCI Comprehensive
48
NCI Comprehensive
49
NCI Comprehensive
50

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →